Alfredo Garcia-Arieta (Alfredo García-Arieta, Alfredo Garcia Arieta)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Benign Prostatic Hyperplasia

Clinical Practice

Lower Urinary Tract Symptoms

Top Venues

British journal of clinical pharmacology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Paulo Paixao, Alfredo Garcia-Arieta, Nuno Elvas Silva, Zvonimir Petric, Milton Bonelli, José Augusto Guimarães Morais, Kevin Blake, Luís Filipe Gouveia
A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics 16 (5) (2024)
Paulo Paixao, Alfredo Garcia-Arieta, Nuno Elvas Silva, Zvonimir Petric, Milton Bonelli, José Augusto Guimarães Morais, Kevin Blake, Luís Filipe Gouveia
A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics 16 (5) (2024)
Efthymios Manolis, Alfredo Garcia-Arieta, Anders Lindahl, Evangelos Kotzagiorgis, Jobst Limberg, Øyvind Holte, Paulo Paixao, Carolien Versantvoort, Flora Musuamba Tshinanu, Kevin Blake, Michiel Van Den Heuvel
Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective. CPT: pharmacometrics & systems pharmacology (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Marival Bermejo, Yasuhiro Tsume, Alejandro Ruiz-Picazo, Marta González-Álvarez, Bart Hens, Alfredo Garcia-Arieta, Greg E Amidon, Gordon L Amidon
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products. Pharmaceutics 13 (4) (2021)
Paulo Paixao, Rita Bento Guerreiro, Nuno Elvas Silva, Kevin Blake, Milton Bonelli, Jose Augusto Guimarães Morais, Alfredo Garcia-Arieta, Luís Filipe Gouveia
A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union. Clinical pharmacology and therapeutics (2021)
Javier Reig-López, Alfredo Garcia-Arieta, Victor Mangas Sanjuan, Matilde Merino-Sanjuán
Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making. Pharmaceutics 13 (5) (2021)
Mercedes Prieto-Escolar, Juan José Torrado, Covadonga Álvarez, Alejandro Ruiz-Picazo, Marta Simón-Vázquez, Carlos Govantes, Jesús Frías, Alfredo Garcia-Arieta, Isabel González-Álvarez, Marival Bermejo
One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products. Pharmaceutics 13 (5) (2021)
Esperanza González-Rojano, Julio Marcotegui, Leonor Laredo, Luther Gwaza, John Gordon, Antonio Portolés, Emilio Vargas, Susana Morales-Alcelay, Alfredo Garcia-Arieta
Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen. Chirality 32 (9) (2020)
Zhengguo Xu, Victor Mangas Sanjuan, Matilde Merino-Sanjuán, Virginia Merino, Alfredo Garcia-Arieta
Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms. Pharmaceutics 12 (12) (2020)
Esperanza González-Rojano, Julio Marcotegui, Dolores Ochoa, Manuel Román, Covadonga Álvarez, John Gordon, Francisco Abad-Santos, Alfredo Garcia-Arieta
Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials. Clinical pharmacology and therapeutics 106 (5) (2019)
Alejandro Ruiz-Picazo, Sarin Colón-Useche, Blanca Perez-Amorós, Marta González-Álvarez, Irene Molina-Martínez, Isabel González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products. Pharmaceutics 11 (12) (2019)
Antonio Matji, Emilio Vargas, Luis Carvajal, Ana Isabel Terleira, Antonio Portolés, Alfredo Garcia-Arieta, Juan José Torrado, Dolores Remedios Serrano
Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compaction. Chirality 32 (2) (2019)
Víctor Mangas-Sanjuán, María Pleguezuelos-Villa, Matilde Merino-Sanjuán, Mª Jesús Hernández, Amparo Nácher, Alfredo Garcia-Arieta, Daniel Peris, Irene Hidalgo, Lluís Soler, Marta Sallan, Virginia Merino
Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence. Pharmaceutics 11 (10) (2019)
Esperanza González-Rojano, Francisco Abad-Santos, John Gordon, Alfredo Garcia-Arieta
Response to 'Sex-by-formulation interaction in bioequivalence studies: the importance of formulations and experimental conditions' by Ibarra et al. British journal of clinical pharmacology 85 (4) (2019)
Zorica Pejčić, Katarina M Vučićević, Alfredo Garcia-Arieta, Branislava Miljković
Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia. British journal of clinical pharmacology 85 (9) (2019)
Esperanza González-Rojano, Francisco Abad-Santos, Dolores Ochoa, Manuel Román, Julio Marcotegui, Covadonga Álvarez, John Gordon, Alfredo Garcia-Arieta
Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets. British journal of clinical pharmacology 84 (8) (2018)